Technical Analysis for JAGX - Jaguar Animal Health, Inc.

Grade Last Price % Change Price Change
grade F 0.725 3.56% 0.02
JAGX closed up 3.56 percent on Wednesday, October 16, 2019, on 37 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical JAGX trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 3.56%
Oversold Stochastic Weakness 3.56%
New 52 Week Closing Low Bearish 6.62%
Stochastic Buy Signal Bullish 6.62%
Narrow Range Bar Range Contraction 6.62%
New 52 Week Low Weakness 6.62%
Wide Bands Range Expansion 6.62%
Down 3 Days in a Row Weakness 6.62%

Older signals for JAGX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar Animal Health, Inc. is a subsidiary of Napo Pharmaceuticals, Inc.
Medicine Medical Specialties Gastroenterology Diarrhea Salix Pharmaceuticals Gastrointestinal Products Gastrointestinal Tract
Is JAGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.55
52 Week Low 0.64
Average Volume 1,268,377
200-Day Moving Average 10.0206
50-Day Moving Average 1.1994
20-Day Moving Average 1.0683
10-Day Moving Average 0.8066
Average True Range 0.1364
ADX 22.47
+DI 17.2996
-DI 32.2634
Chandelier Exit (Long, 3 ATRs ) 1.1908
Chandelier Exit (Short, 3 ATRs ) 1.0492
Upper Bollinger Band 1.6341
Lower Bollinger Band 0.5025
Percent B (%b) 0.2
BandWidth 105.925302
MACD Line -0.1928
MACD Signal Line -0.1638
MACD Histogram -0.029
Fundamentals Value
Market Cap 78.43 Million
Num Shares 108 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -4.65
Price-to-Sales 11.19
Price-to-Book 0.00
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.85
Resistance 3 (R3) 0.85 0.82 0.83
Resistance 2 (R2) 0.82 0.78 0.81 0.82
Resistance 1 (R1) 0.77 0.77 0.79 0.77 0.81
Pivot Point 0.73 0.73 0.75 0.73 0.73
Support 1 (S1) 0.69 0.70 0.71 0.68 0.64
Support 2 (S2) 0.65 0.68 0.65 0.63
Support 3 (S3) 0.61 0.65 0.62
Support 4 (S4) 0.60